Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Form 8.3 - Willis Towers Watson plc - Amendment

7th Jul 2020 10:08

 

Ap19

FORM 8.3 - Amendment to Purchase and Sales

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)Barclays PLC.
Company dealt inWILLIS TOWERS WATSON PLC
Class of relevant security to which theORD
dealings being disclosed relate (Note 2)
Date of dealing01 July 2020

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security:

ORD

 

 

Long

Short

Number

(%)

Number

(%)

(1)

Relevant securities

 

 

 

 

1,405,644

1.09%

466,360

0.36%

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

333,000

0.26%

383,659

0.30%

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

0

0.00%

0

0.00%

 

 

 

 

TOTAL:

 

 

 

 

1,738,644

1.35%

850,019

0.66%

 

 

 

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale

Number of relevant securities

Price per unit
Purchase

1

195.6000 USD
Purchase

25

196.0756 USD
Purchase

50

196.2000 USD
Purchase

63

196.1300 USD
Purchase

100

195.3900 USD
Purchase

100

195.3500 USD
Purchase

100

195.3400 USD
Purchase

100

195.4150 USD
Purchase

130

195.9078 USD
Purchase

200

195.9150 USD
Purchase

200

195.3575 USD
Purchase

200

195.6925 USD
Purchase

400

195.4375 USD
Purchase

446

196.0767 USD
Purchase

500

195.5850 USD
Purchase

500

196.1600 USD
Purchase

516

196.0318 USD
Purchase

517

195.7303 USD
Purchase

894

195.8172 USD
Purchase

1,126

195.5439 USD
Purchase

1,441

196.0198 USD
Purchase

1,600

195.6506 USD
Purchase

3,339

195.4826 USD
Purchase

4,180

196.0582 USD
Purchase

13,306

195.6065 USD
Purchase

15,450

195.9103 USD
Purchase

37,108

195.2500 USD
Purchase

98,680

195.8537 USD
Sale

2

195.8750 USD
Sale

2

196.7700 USD
Sale

3

196.2666 USD
Sale

3

195.8150 USD
Sale

4

195.6100 USD
Sale

5

195.8600 USD
Sale

14

195.6935 USD
Sale

17

195.7400 USD
Sale

18

196.0133 USD
Sale

18

195.9716 USD
Sale

21

196.1642 USD
Sale

22

195.8650 USD
Sale

46

195.7000 USD
Sale

63

196.1300 USD
Sale

100

196.1200 USD
Sale

100

195.9100 USD
Sale

100

195.8400 USD
Sale

100

196.1800 USD
Sale

150

196.2000 USD
Sale

158

196.0607 USD
Sale

194

196.5300 USD
Sale

200

196.1850 USD
Sale

213

196.5261 USD
Sale

250

196.3200 USD
Sale

300

196.1000 USD
Sale

349

195.3033 USD
Sale

369

197.0300 USD
Sale

400

196.1700 USD
Sale

472

195.3878 USD
Sale

724

195.8966 USD
Sale

764

196.1791 USD
Sale

867

195.9648 USD
Sale

933

196.0971 USD
Sale

1,116

196.2283 USD
Sale

1,200

195.6950 USD
Sale

1,404

195.8620 USD
Sale

1,441

196.0198 USD
Sale

2,276

195.5357 USD
Sale

2,288

195.6502 USD
Sale

2,688

196.1140 USD
Sale

3,179

196.0996 USD
Sale

3,568

195.9125 USD
Sale

3,940

196.1325 USD
Sale

4,733

195.8356 USD
Sale

5,300

196.2985 USD
Sale

5,377

196.1551 USD
Sale

5,812

195.8149 USD
Sale

6,490

196.0475 USD
Sale

6,931

195.4881 USD
Sale

7,228

195.8821 USD
Sale

13,124

195.9675 USD
Sale

13,223

195.6146 USD
Sale

37,116

195.2500 USD
Sale

45,857

195.6821 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached?NO
Date of disclosure:

3 Jul 2020

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20200707005380/en/

Copyright Business Wire 2020


Related Shares:

Barclays
FTSE 100 Latest
Value8,875.22
Change24.59